| Bioactivity | p38-α MAPK-IN-7 (compound 4) is a p38α-MAPK inhibitor with an IC50 value of 98.7 nM. p38-α MAPK-IN-7 protects neuronal cells from dexamethasone-induced ROS production[1]. |
| Formula | C23H14Cl2F2N4OS |
| Molar Mass | 503.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Claudia Albertini, et al. Targeting Lewy body dementia with neflamapimod-rasagiline hybrids. Arch Pharm (Weinheim). 2024. |